PharmaTher Announces Positive Research Results for PharmaPatch™ with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics Post published:July 18, 2023 Post category:Press Release
Clearmind Medicine Announces Share-Based Payment for the Company’s Consultants Post published:July 18, 2023 Post category:Press Release
Numinus Wellness Inc. Reports Q3 2023 Results Post published:July 17, 2023 Post category:Press Release
Psychedelic Bulletin #141: Terran’s 4-OH-DiPT Prodrug Patent App.; Generic Ketamine Appears Effective for TRD; VA/DoD Guideline Reviews Psychedelics Post published:July 17, 2023 Post category:Psychedelic Bulletin
COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal, Neuropsychopharmacology Post published:July 17, 2023 Post category:Press Release
Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement Post published:July 15, 2023 Post category:Press Release
Reunion Neuroscience Inc. Obtains Final Court Order for Proposed Plan of Arrangement Post published:July 14, 2023 Post category:Press Release
Reunion Neuroscience Inc. Shareholders Approve Proposed Plan of Arrangement Post published:July 13, 2023 Post category:Press Release
BetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placement Post published:July 13, 2023 Post category:Press Release